BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6270740)

  • 1. Prostaglandin E2 elevation of cyclic-AMP in granuloma macrophages at various stages of inflammation: relevance to anti-inflammatory and immunomodulatory functions.
    Bonta IL; Adolfs MJ; Parnham MJ
    Prostaglandins; 1981 Jul; 22(1):95-103. PubMed ID: 6270740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction between responsiveness of macrophages to cyclic-AMP elevation by prostaglandin E2 and prostacyclin.
    Bonta IL; Adolfs MJ; Parnham MJ
    Scand J Rheumatol Suppl; 1981; 40():58-61. PubMed ID: 6100917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP in macrophages from experimental granulomas and the effect of prostaglandin E2.
    Adolfs MJ; Bonta IL; Parnham MJ
    Agents Actions; 1980 Dec; 10(6):561-3. PubMed ID: 6267915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid, an in vivo inhibitor of carrageenin induced granulomas in the rat.
    Elliott GR; Adolfs MJ; Bonta IL
    Eur J Pharmacol; 1985 Apr; 110(3):367-71. PubMed ID: 2988985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages as targets of inhibitory effects of E-type prostaglandins in immune-related inflammation.
    Bonta IL; Parnham MJ
    Agents Actions; 1981 Dec; 11(6-7):594-7. PubMed ID: 6280464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low concentrations of prostaglandin E2 inhibit the prostacyclin-induced elevation of cyclic adenosine 3',5'-monophosphate in elicited populations of rat peritoneal macrophages.
    Adolfs MJ; Bonta IL
    Br J Pharmacol; 1982 Feb; 75(2):373-6. PubMed ID: 6313108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between prostaglandin E2 and prostacyclin in regulating levels of cyclic AMP in elicited populations of peritoneal macrophages.
    Bonta IL; Adolfs MJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():13-7. PubMed ID: 6303080
    [No Abstract]   [Full Text] [Related]  

  • 8. Linoleic and dihomo-gamma-linolenic acids modulate granuloma growth and granuloma macrophage eicosanoid release.
    Elliott GR; Adolfs MJ; Van Batenburg M; Bonta IL
    Eur J Pharmacol; 1986 May; 124(3):325-9. PubMed ID: 3460810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of prostaglandin E2 and cyclic AMP on release of arachidonic acid metabolites from resting and lipopolysaccharide-stimulated macrophages.
    Feuerstein N; Ramwell PW
    Br J Pharmacol; 1984 Nov; 83(3):759-62. PubMed ID: 6095961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiinflammatory aspects of exogenous arachidonic acid.
    Elliott GR; Adolfs MJ; Bonta IL
    Agents Actions Suppl; 1984; 14():207-13. PubMed ID: 6089527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity of prostaglandin E2 receptor in human macrophages and the ternary complex of adenylate cyclase.
    Adolfs MJ; Bonta IL
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():459-62. PubMed ID: 2889337
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophage regulation of collagen deposition in granuloma tissue in vivo and the effect of prostaglandin E2.
    Parnham MJ; Shoshan S; Schoenmaker H; Bonta IL
    Scand J Rheumatol Suppl; 1981; 40():72-4. PubMed ID: 6100919
    [No Abstract]   [Full Text] [Related]  

  • 13. Infectious-inflammatory changes in cyclic AMP levels and in their regulation by prostaglandins in human peritoneal macrophages.
    Adolfs MJ; Fieren MW; Bonta IL
    Prostaglandins Leukot Med; 1985 May; 18(2):217-26. PubMed ID: 2989936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen metabolism and phenotype after prostaglandin E2 treatment of granuloma: direct and macrophage-modulated effects.
    Parnham MJ; Shoshan S; Schoenmaker H; Bonta IL
    Prostaglandins; 1982 Jan; 23(1):85-98. PubMed ID: 6950463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulation by macrophages. III. Prostaglandin E suppresses lymphocyte activation but not macrophage effector function during Salmonella enteritidis infection.
    Cahill J; Hopper KE
    Int J Immunopharmacol; 1984; 6(1):9-17. PubMed ID: 6327542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and further studies on the activity of prostaglandin E in chronic granulomatous inflammation.
    Bonta IL; Adolfs MJ; Parnham MJ
    Agents Actions Suppl; 1979; (6):121-32. PubMed ID: 230731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the desensitization of growth hormone and cyclic AMP responses to growth hormone-releasing factor and prostaglandin E2 in rat anterior pituitary cells in culture.
    Simard J; Labrie F
    Mol Cell Endocrinol; 1986 Jun; 46(1):79-89. PubMed ID: 2423397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP levels and their regulation by prostaglandins in peritoneal macrophages of rats and humans.
    Bonta IL; Adolfs MJ; Fieren MW
    Int J Immunopharmacol; 1984; 6(6):547-55. PubMed ID: 6210257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of macrophage collagenase, prostaglandin, and fibroblast-activating-factor production by anti-inflammatory agents: different regulatory mechanisms for tissue injury and repair.
    Wahl SM; Wahl LM
    Cell Immunol; 1985 May; 92(2):302-12. PubMed ID: 2986853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of the cyclooxygenase pathway in starch elicited rat peritoneal macrophages by prostaglandin E2, U-44069, a stable endoperoxide analogue and dibutyryl-cyclic AMP.
    Elliott GR; Van Batenburg MJ; Bonta IL
    Eur J Pharmacol; 1985 Aug; 114(1):71-4. PubMed ID: 2995076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.